[Controlled clinical study on 2 antialdosterone diuretics in the nephrotic syndrome].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002191:Canrenoic Acid / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004231:Diuresis / Q000187:drug effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D011245:Pregnadienes / Q000627:therapeutic use*; D013148:Spironolactone / Q000627:therapeutic use
D011245:Pregnadienes; D013148:Spironolactone; D002191:Canrenoic Acid
Studio clinico controllato su due diuretici antialdosteronici nella sindrome nefrosica.